EDAP TMS S.A. (EDAP)

7,13 -0,23 (-3,13%) Alla chiusura: 04:00PM EDT

EDAP TMS S.A.

Parc dActivites la Poudrette-Lamartine
4/6, rue du DauphinE Vaulx-en-Velin
Lyon 69120
France
33 4 72 153 150
https://www.edap-tms.com

Settore/i: Healthcare
Settore: Medical Distribution
Impiegati a tempo pieno: 307

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Marc Oczachowski	Executive Chairman	N/D	N/D	1970
Mr. Ryan Rhodes	CEO & Director	N/D	N/D	1962
Mr. Ken Mobeck	Chief Financial Officer	N/D	N/D	1971
Mr. Carre Emmanuel	Chief Operating Officer	N/D	N/D	N/D
Mr. Francois Dietsch	Chief Accounting Officer	N/D	N/D	1976
Ms. Blandine Confort	Head of Legal Affairs & Investor Relations and Secretary	N/D	N/D	N/D
Mr. Frederic Pech	President of EDAP TMS France	N/D	N/D	1969
Mr. Jean-Francois Bachelard	President & Chief Executive Officer of Edaptechnomed Co. Ltd.	N/D	N/D	1964

Gli importi risalgono al giorno e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments. The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment also offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology; and offers Sonolith i-move, an extracorporeal shockwave lithotripter, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. It markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. The company serves hospitals, urology clinics, and research institutions. EDAP TMS S.A. was incorporated in 1979 and is based in Lyon, France.

Governance aziendale

L'ISS Governance QualityScore di EDAP TMS S.A. al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.